NCT05638295 2026-03-19
Testing the Use of AMG 510 (Sotorasib) and Panitumumab as a Targeted Treatment for KRAS G12C Mutant Solid Tumor Cancers (A ComboMATCH Treatment Trial)
National Cancer Institute (NCI)
Phase 2 Recruiting
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of California, San Francisco
National Cancer Institute (NCI)
NRG Oncology
University of California, San Francisco
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
Nuclear Imaging Institute
Mayo Clinic
National Cancer Institute (NCI)
City of Hope Medical Center
Nuclear Imaging Institute
University of California, San Francisco
Centre Hospitalier Universitaire, Amiens